AB0707 Comparative effectiveness of secukinumab and golimumab in ankylosing spondylitis assessed by matching-adjusted indirect comparison using pivotal phase 3 clinical trial data

Author(s):

W Maksymowych ◽

E Choy ◽

Y Yazici ◽

J Walsh ◽

H Thom ◽

...

Keyword(s):

Clinical Trial ◽

Ankylosing Spondylitis ◽

Indirect Comparison ◽

Clinical Trial Data ◽

Trial Data ◽

Phase 3 ◽

Pivotal Phase ◽

Comparative Effectiveness of Secukinumab and Adalimumab in Ankylosing Spondylitis as Assessed by Matching-Adjusted Indirect Comparison: An Analysis Based on All Pivotal Phase 3 Clinical Trial Data

Value in Health ◽

10.1016/j.jval.2017.08.2959 ◽

2017 ◽

Vol 20 (9) ◽

pp. A935 ◽

Cited By ~ 2

Author(s):

WP Maksymowych ◽

J Walsh ◽

H Thom ◽

C Kalyvas ◽

GF Rosal ◽

...

Keyword(s):

Clinical Trial ◽

Ankylosing Spondylitis ◽

Indirect Comparison ◽

Clinical Trial Data ◽

Trial Data ◽

Phase 3 ◽

Pivotal Phase ◽

173 Comparative effectiveness of secukinumab and golimumab in ankylosing spondylitis assessed by matching-adjusted indirect comparison using pivotal phase III clinical trial data

Rheumatology ◽

10.1093/rheumatology/key075.397 ◽

2018 ◽

Vol 57 (suppl_3) ◽

Author(s):

Hasan Tahir ◽

Walter Maksymowych ◽

Ernest Choy ◽

Yusuf Yazici ◽

Jessica Walsh ◽

...

Keyword(s):

Clinical Trial ◽

Ankylosing Spondylitis ◽

Indirect Comparison ◽

Clinical Trial Data ◽

Trial Data ◽

Phase Iii ◽

Pivotal Phase ◽

Phase Iii Clinical Trial ◽

SAT0480 Comparative effectiveness of secukinumab and infliximab in psoriatic arthritis assessed by matching-adjusted indirect comparison using pivotal phase 3 clinical trial data

10.1136/annrheumdis-2017-eular.5802 ◽

2017 ◽

Author(s):

V Strand ◽

I McInnes ◽

P Mease ◽

E Choy ◽

P Nash ◽

...

Keyword(s):

Clinical Trial ◽

Psoriatic Arthritis ◽

Indirect Comparison ◽

Clinical Trial Data ◽

Trial Data ◽

Phase 3 ◽

Pivotal Phase ◽

175 Comparative effectiveness of secukinumab and infliximab in psoriatic arthritis assessed by matching-adjusted indirect comparison using pivotal Phase III clinical trial data

Rheumatology ◽

10.1093/rheumatology/key075.399 ◽

2018 ◽

Vol 57 (suppl_3) ◽

Author(s):

Arvind Kaul ◽

Vibeke Strand ◽

Iain McInnes ◽

Philip Mease ◽

Ernest Choy ◽

...

Keyword(s):

Clinical Trial ◽

Psoriatic Arthritis ◽

Indirect Comparison ◽

Clinical Trial Data ◽

Trial Data ◽

Phase Iii ◽

Pivotal Phase ◽

Phase Iii Clinical Trial ◽

Matching-Adjusted Indirect Comparison (MAIC) Of Crizotinib With Standard of Care In Progressed Nsclc ALK+ Patients Based On Real-World Evidence (RWE) And Clinical Trial Data In The Czech Republic

Value in Health ◽

10.1016/j.jval.2017.08.100 ◽

2017 ◽

Vol 20 (9) ◽

pp. A414

Author(s):

B Pasztor ◽

L Losenicky ◽

P Mazan ◽

J Duba ◽

M Kolek

Keyword(s):

Clinical Trial ◽

Czech Republic ◽

Real World ◽

Indirect Comparison ◽

Clinical Trial Data ◽

Standard Of Care ◽

Trial Data ◽

The Czech Republic ◽

Real World Evidence ◽

Comparative efficacy of ravulizumab and eculizumab in the treatment of atypical hemolytic uremic syndrome: An indirect comparison using clinical trial data

Clinical Nephrology ◽

10.5414/cn110516 ◽

2021 ◽

Author(s):

Ioannis Tomazos ◽

Anthony J. Hatswell ◽

Spero Cataland ◽

Peter Chen ◽

Nick Freemantle ◽

...

Keyword(s):

Clinical Trial ◽

Hemolytic Uremic Syndrome ◽

Atypical Hemolytic Uremic Syndrome ◽

Indirect Comparison ◽

Clinical Trial Data ◽

Trial Data ◽

Comparative Efficacy ◽

Uremic Syndrome

PRM57 Developing BASDAI and BASFI Predictive Equations From Clinical Trial Data of Golimumab for Severe, Active Ankylosing Spondylitis in Adults

Value in Health ◽

10.1016/j.jval.2012.08.1520 ◽

2012 ◽

Vol 15 (7) ◽

pp. A470

Author(s):

M.A. Chaudhary ◽

B. Hsu ◽

N. Muszbek ◽

I. Proskorovsky ◽

J. Farrell

Keyword(s):

Clinical Trial ◽

Ankylosing Spondylitis ◽

Clinical Trial Data ◽

Trial Data ◽

Predictive Equations

Clinical cure rates in subjects treated with azithromycin for community-acquired respiratory tract infections caused by azithromycin-susceptible or azithromycin-resistant Streptococcus pneumoniae: analysis of Phase 3 clinical trial data

Journal of Antimicrobial Chemotherapy ◽

10.1093/jac/dku207 ◽

2014 ◽

Vol 69 (10) ◽

pp. 2835-2840 ◽

Cited By ~ 13

Author(s):

G. G. Zhanel ◽

K. D. Wolter ◽

C. Calciu ◽

P. Hogan ◽

D. E. Low ◽

...

Keyword(s):

Clinical Trial ◽

Streptococcus Pneumoniae ◽

Respiratory Tract ◽

Clinical Cure ◽

Respiratory Tract Infections ◽

Clinical Trial Data ◽

Trial Data ◽

Phase 3 ◽

Tract Infections ◽

Cure Rates

Comment on: Clinical cure rates in subjects treated with azithromycin for community-acquired respiratory tract infections caused by azithromycin-susceptible or azithromycin-resistantStreptococcus pneumoniae: analysis of Phase 3 clinical trial data

Journal of Antimicrobial Chemotherapy ◽

10.1093/jac/dkv212 ◽

2015 ◽

Vol 70 (11) ◽

pp. 3170.1-3170 ◽

Author(s):

Andrew Kirby

Keyword(s):

Clinical Trial ◽

Respiratory Tract ◽

Clinical Cure ◽

Respiratory Tract Infections ◽

Clinical Trial Data ◽

Trial Data ◽

Phase 3 ◽

Tract Infections ◽

Cure Rates

Comment: Sodium-Glucose Cotransporters as Potential Therapeutic Targets in Patients With Type 1 Diabetes Mellitus: An Update on Phase 3 Clinical Trial Data

Annals of Pharmacotherapy ◽

10.1177/1060028020910204 ◽

2020 ◽

Vol 54 (9) ◽

pp. 939-940 ◽

Author(s):

Medine Cumhur Cure ◽

Erkan Cure

Keyword(s):

Diabetes Mellitus ◽

Clinical Trial ◽

Type 1 Diabetes ◽

Type 1 Diabetes Mellitus ◽

Therapeutic Targets ◽

Clinical Trial Data ◽

Trial Data ◽

Phase 3